These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 18574935)
21. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms. Singh VY; Chacko G; Chacko AG; Rajshekhar V Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451 [TBL] [Abstract][Full Text] [Related]
22. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features. van den Bent MJ; Looijenga LH; Langenberg K; Dinjens W; Graveland W; Uytdewilligen L; Sillevis Smitt PA; Jenkins RB; Kros JM Cancer; 2003 Mar; 97(5):1276-84. PubMed ID: 12599236 [TBL] [Abstract][Full Text] [Related]
23. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A; Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167 [TBL] [Abstract][Full Text] [Related]
24. Anaplastic oligodendroglioma arising from the brain stem and featuring 1p/19q co-deletion. Hewer E; Beck J; Vassella E; Vajtai I Neuropathology; 2014 Feb; 34(1):32-8. PubMed ID: 23711170 [TBL] [Abstract][Full Text] [Related]
25. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma. Sathornsumetee S; Cheunsuchon P; Sangruchi T World Neurosurg; 2016 Jul; 91():518-523.e1. PubMed ID: 26960282 [TBL] [Abstract][Full Text] [Related]
26. Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients. Wang K; Wang Y; Fan X; Li Y; Liu X; Wang J; Ai L; Dai J; Jiang T J Neurooncol; 2018 Feb; 136(3):523-531. PubMed ID: 29230668 [TBL] [Abstract][Full Text] [Related]
27. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic. Li YX; Shi Z; Aibaidula A; Chen H; Tang Q; Li KK; Chung NY; Chan DT; Poon WS; Mao Y; Wu J; Zhou L; Chan AK; Ng HK Oncotarget; 2016 Oct; 7(40):64615-64630. PubMed ID: 27556304 [TBL] [Abstract][Full Text] [Related]
28. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559 [TBL] [Abstract][Full Text] [Related]
29. [Correlation of chromosome 1p and 19q status and expression of R132H mutant IDH1 protein in oligodendroglial tumors]. Yao K; Duan Z; Hu Z; Bian Y; Qi X Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):663-7. PubMed ID: 25567591 [TBL] [Abstract][Full Text] [Related]
30. Chromosome 1p and 19q evaluation in low-grade oligodendrogliomas: a descriptive study. Molinari C; Iorio P; Medri L; Ballardini M; Guiducci G; Cremonini AM; Cerasoli S; Riccioni L; Faedi M; Mariani GA; Zoli W; Silvestrini R; Calistri D Int J Mol Med; 2010 Jan; 25(1):145-51. PubMed ID: 19956913 [TBL] [Abstract][Full Text] [Related]
31. Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma. Cairncross G; Jenkins R Cancer J; 2008; 14(6):352-7. PubMed ID: 19060598 [TBL] [Abstract][Full Text] [Related]
32. Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion. Gladitz J; Klink B; Seifert M Acta Neuropathol Commun; 2018 Jun; 6(1):49. PubMed ID: 29890994 [TBL] [Abstract][Full Text] [Related]
34. Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions. Sonabend AM; Lesniak MS Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S25-32. PubMed ID: 16274268 [TBL] [Abstract][Full Text] [Related]
35. Leptomeningeal metastases in glioma: The Memorial Sloan Kettering Cancer Center experience. Andersen BM; Miranda C; Hatzoglou V; DeAngelis LM; Miller AM Neurology; 2019 May; 92(21):e2483-e2491. PubMed ID: 31019097 [TBL] [Abstract][Full Text] [Related]
36. Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors. Srebotnik-Kirbiš I; Limbäck-Stokin C J Neurooncol; 2016 Sep; 129(3):415-422. PubMed ID: 27406587 [TBL] [Abstract][Full Text] [Related]
37. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p. Hashimoto N; Murakami M; Takahashi Y; Fujimoto M; Inazawa J; Mineura K Cancer; 2003 May; 97(9):2254-61. PubMed ID: 12712480 [TBL] [Abstract][Full Text] [Related]
38. The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients. Hacisalihoglu P; Kucukodaci Z; Gundogdu G; Bilgic B Turk Neurosurg; 2017; 27(5):682-689. PubMed ID: 27651340 [TBL] [Abstract][Full Text] [Related]
39. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Ino Y; Betensky RA; Zlatescu MC; Sasaki H; Macdonald DR; Stemmer-Rachamimov AO; Ramsay DA; Cairncross JG; Louis DN Clin Cancer Res; 2001 Apr; 7(4):839-45. PubMed ID: 11309331 [TBL] [Abstract][Full Text] [Related]
40. Spinal leptomeningeal oligodendrogliomatosis after resection of cerebral anaplastic oligodendoglioma with 1p19q Co-deletion - A case report. Felipe Andres MJ; Fouzia Z; Sami R J Clin Neurosci; 2020 Mar; 73():314-316. PubMed ID: 32007374 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]